ArticleHealthcare informatics research2026
Early Detection of Parkinson's Disease Using Automatic Classification of Single-photon Emission Computed Tomography Images.
Article in Healthcare informatics research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesParkinson's disease (PD) is a chronic neurodegenerative disorder characterized by central nervous system dysfunction. Early identification may enable prompt treatment and help slow the progression of disabling symptoms. Previous studies have reported that clinical assessments based on visual interpretation may be insufficiently accurate and often miss early PD. Therefore, this study aimed to develop an automated single-photon emission computed tomography-based model for binary classification of healthy controls and patients with early PD.
methodsWe analyzed 514 DaTSCAN images from the Parkinson's Progression Markers Initiative database, using one unique scan per individual. The workflow comprised three main stages: image processing; computation of 23 features, including radial, threshold, boundary, and striatal binding ratio features; and image classification using machine learning algorithms.
resultsThe medium Gaussian support vector machine achieved an accuracy of 97.09% ± 1.53% (95% confidence interval, 95.11%-99.07%), sensitivity of 98.18% ± 1.48%, specificity of 93.85% ± 3.44%, and area under the receiver operating characteristic curve of 98.49% ± 1.31%. This performance was significantly higher than that of the three-dimensional convolutional neural network baseline model (accuracy, 94.55% ± 2.98%; p = 0.045), while requiring substantially less training time.
conclusionsIn this dataset, carefully designed feature engineering combined with classical machine learning outperformed the deep-learning baseline when the training data were limited and the selected features aligned with clinical diagnostic criteria. This approach achieved high accuracy for early PD detection and may provide computational efficiency and interpretability suitable for clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.